Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A*11:01.

Gu Y, Wong YH, Liew CW, Chan CEZ, Murali TM, Yap J, Too CT, Purushotorman K, Hamidinia M, El Sahili A, Goh ATH, Teo RZC, Wood KJ, Hanson BJ, Gascoigne NRJ, Lescar J, Vathsala A, MacAry PA.

Nat Commun. 2019 Feb 21;10(1):893. doi: 10.1038/s41467-019-08790-1.

2.

The heat is on: A device that reduces cold stress-induced tachycardia in laboratory mice.

Chan CE, Hare MT, Martin GW, Gordon CJ, Swoap SJ.

J Therm Biol. 2019 Jan;79:149-154. doi: 10.1016/j.jtherbio.2018.12.006. Epub 2018 Dec 13.

PMID:
30612675
3.

Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells.

Park HY, Tan PS, Kavishna R, Ker A, Lu J, Chan CEZ, Hanson BJ, MacAry PA, Caminschi I, Shortman K, Alonso S, Lahoud MH.

NPJ Vaccines. 2017 Nov 6;2:31. doi: 10.1038/s41541-017-0033-5. eCollection 2017.

4.

TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants.

Lai J, Choo JAL, Tan WJ, Too CT, Oo MZ, Suter MA, Mustafa FB, Srinivasan N, Chan CEZ, Lim AGX, Zhong Y, Chan SH, Hanson BJ, Gascoigne NRJ, MacAry PA.

Sci Rep. 2017 Aug 30;7(1):9923. doi: 10.1038/s41598-017-10265-6.

5.

Shifting the optimal stiffness for cell migration.

Bangasser BL, Shamsan GA, Chan CE, Opoku KN, Tüzel E, Schlichtmann BW, Kasim JA, Fuller BJ, McCullough BR, Rosenfeld SS, Odde DJ.

Nat Commun. 2017 May 22;8:15313. doi: 10.1038/ncomms15313.

6.

Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1.

Wang L, Chan CEL, Wong AL, Wong FC, Lim SW, Chinnathambi A, Alharbi SA, Lee LS, Soo R, Yong WP, Lee SC, Ho PC, Sethi G, Goh BC.

Oncotarget. 2017 Jun 20;8(25):41572-41581. doi: 10.18632/oncotarget.15017.

7.

The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective.

Lim SY, Chan CE, Lisowska MM, Hanson BJ, MacAry PA.

PLoS One. 2015 Dec 23;10(12):e0145381. doi: 10.1371/journal.pone.0145381. eCollection 2015.

8.

The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis.

Chan CE, Götze S, Seah GT, Seeberger PH, Tukvadze N, Wenk MR, Hanson BJ, MacAry PA.

Sci Rep. 2015 May 15;5:10281. doi: 10.1038/srep10281.

9.

The role of phage display in therapeutic antibody discovery.

Chan CE, Lim AP, MacAry PA, Hanson BJ.

Int Immunol. 2014 Dec;26(12):649-57. doi: 10.1093/intimm/dxu082. Epub 2014 Aug 18. Review.

PMID:
25135889
10.

Novel phage display-derived mycolic acid-specific antibodies with potential for tuberculosis diagnosis.

Chan CE, Zhao BZ, Cazenave-Gassiot A, Pang SW, Bendt AK, Wenk MR, MacAry PA, Hanson BJ.

J Lipid Res. 2013 Oct;54(10):2924-32. doi: 10.1194/jlr.D036137. Epub 2013 Jun 24.

11.

Label-free electronic detection of bio-toxins using aligned carbon nanotubes.

Palaniappan A, Goh WH, Fam DW, Rajaseger G, Chan CE, Hanson BJ, Moochhala SM, Mhaisalkar SG, Liedberg B.

Biosens Bioelectron. 2013 May 15;43:143-7. doi: 10.1016/j.bios.2012.12.019. Epub 2012 Dec 14.

PMID:
23298625
12.

Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.

Islam MO, Lim YT, Chan CE, Cazenave-Gassiot A, Croxford JL, Wenk MR, Macary PA, Hanson BJ.

Int J Mol Sci. 2012;13(4):4937-48. doi: 10.3390/ijms13044937. Epub 2012 Apr 19.

13.

Comparison of the efficiency of antibody selection from semi-synthetic scFv and non-immune Fab phage display libraries against protein targets for rapid development of diagnostic immunoassays.

Chan CE, Chan AH, Lim AP, Hanson BJ.

J Immunol Methods. 2011 Oct 28;373(1-2):79-88. doi: 10.1016/j.jim.2011.08.005. Epub 2011 Aug 12.

PMID:
21856306
14.

Optimized expression of full-length IgG1 antibody in a common E. coli strain.

Chan CE, Lim AP, Chan AH, MacAry PA, Hanson BJ.

PLoS One. 2010 Apr 20;5(4):e10261. doi: 10.1371/journal.pone.0010261.

15.

The use of antibodies in the treatment of infectious diseases.

Chan CE, Chan AH, Hanson BJ, Ooi EE.

Singapore Med J. 2009 Jul;50(7):663-72; quiz 673. Review.

16.

Traction dynamics of filopodia on compliant substrates.

Chan CE, Odde DJ.

Science. 2008 Dec 12;322(5908):1687-91. doi: 10.1126/science.1163595.

17.

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.

Lim AP, Chan CE, Wong SK, Chan AH, Ooi EE, Hanson BJ.

Virol J. 2008 Oct 28;5:130. doi: 10.1186/1743-422X-5-130.

18.

Refractory headaches due to multilevel thoracic cerebrospinal fluid leaks.

Trentman TL, Chan CE, Patel NP, Dodick DW, Nelson KD, Schwedt TJ, Seamans DP.

Pain Pract. 2008 Sep-Oct;8(5):394-8. doi: 10.1111/j.1533-2500.2008.00225.x. Epub 2008 Aug 6.

PMID:
18694451
19.

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.

Lim AP, Wong SK, Chan AH, Chan CE, Ooi EE, Hanson BJ.

Virol J. 2008 Jul 11;5:80. doi: 10.1186/1743-422X-5-80.

20.

Antilactoferrin antibody in systemic lupus erythematosus.

Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH, Chau KF.

Br J Rheumatol. 1992 Oct;31(10):669-73.

PMID:
1393372
21.

A comparison of pneumogram recordings in infants in the hospital and at home.

Keens TG, Ward SL, Gates EP, Hart LD, Basile A, Tinajero LA, Lau AM, Chan CE.

Pediatr Pulmonol. 1986 Nov-Dec;2(6):373-7.

PMID:
3643507

Supplemental Content

Support Center